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Relative effect of urinary calcium and oxalate on saturation of
calcium oxalate.
Background. The study compared the effect of urinary cal-
cium with that of oxalate on urinary saturation [relative satura-
tion ratio (RSR)] of calcium oxalate.
Methods. A retrospective data analysis was conducted on uri-
nary stone risk analysis from 667 patients with predominantly
calcium oxalate stones. Urinary RSR of calcium oxalate was in-
dividually calculated using Equil 2. A “theoretical” curve of the
relationship between urinary RSR of calcium oxalate and con-
centration of calcium or oxalate was obtained at two stability
constants for calcium oxalate complex, while varying calcium or
oxalate and using group mean values for urinary constituents.
Results. At the stability constant of 7.07 × 103, the increase in
RSR of calcium oxalate was less marked with calcium than with
oxalate. However, at the stability constant of 2.746 × 103 from
the Equil 2 that is considered the “gold standard,” calcium and
oxalate were equally effective in increasing RSR of calcium ox-
alate. The above theoretical curves (relating RSR with calcium
or oxalate) were closely approximated by the actual curves con-
structed with data from individual urine samples. Urinary sat-
uration of calcium oxalate was equally dependent on urinary
concentrations of calcium and oxalate (r = 0.75 unadjusted and
0.57 adjusted for variables, and P < 0.0001 for calcium; r = 0.73
unadjusted and 0.60 adjusted, P <0.0001 for oxalate).
Conclusion. Among calcium oxalate stone-formers, urinary
calcium is equally effective as urinary oxalate in increasing RSR
of calcium oxalate.
A topic of considerable interest and continuing debate
in nephrolithiasis field concerns the relative importance
of urinary calcium and oxalate in the formation of cal-
cium oxalate stones. The basis of this controversy is the
so-called “calcium oxalate interaction,” involving inter-
action between calcium and oxalate in the urine [1]. In
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the urinary environment, calcium forms a soluble com-
plex with oxalate, reducing both the ionized calcium and
oxalate [2]. Since the amount of oxalate (in milliequiv-
alent amounts) in urine is normally much less than that
of calcium, it has been suggested that a proportionately
much greater decline in ionized oxalate would occur than
in ionized calcium as a result of calcium oxalate complex
formation. Thus, according to this scheme, a rise in cal-
cium concentration would be offset by a decline in ionized
oxalate concentration, blunting the increase in urinary
saturation of calcium oxalate. Conversely, a rise in ox-
alate concentration would cause a proportionally smaller
decline in ionized calcium concentration, causing a more
prominent increase in urinary saturation of calcium
oxalate.
Thus, in 1972, Nordin, Peacock, and Wilkinson [2] re-
ported that the rise in urinary calcium concentration was
less effective in increasing urinary saturation of calcium
oxalate, compared with urinary oxalate concentration.
Even at high calcium concentration, the saturation of
calcium oxalate did not exceed the theoretic formation
product (the limit of metastability above which precipi-
tation of calcium oxalate takes place), whereas the forma-
tion product was exceeded at high oxalate concentration.
This concept, invoking a greater pathogenetic role of uri-
nary oxalate over calcium, has persisted through today
[3–5].
It should be apparent, however, that the degree of cal-
cium oxalate interaction in urine depends on the stabil-
ity constant for the formation of soluble calcium oxalate
complex used in the calculation of calcium oxalate sat-
uration. Higher the stability constant, a more soluble
complex would form and blunt the effect of calcium on
calcium oxalate saturation. In 1976, Robertson et al [6] ac-
knowledged that the stability constant employed by them
in 1972 [2] had been too high, and changed it to a much
lower value (from 7.07 × 103 to 1.9 × 103). However,
they had not reexamined the effect of calcium or oxalate
concentration on the saturation of calcium oxalate.
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The stability constant is now acknowledged to be
2.746 × 103, as first reported by Finlayson, Roth, and
DuBois [7]; this is the value used in the Equil 2 program
[8], considered the gold standard for calculating urinary
saturation of stone-forming salts. In 1982, we used the
two stability constants to calculate saturation of calcium
oxalate in a synthetic solution simulating urinary envi-
ronment [9]. We found that the ability of calcium concen-
tration to increase the saturation of calcium oxalate was
much more marked when the lower stability constant of
Finlayson, Roth, and DuBois [7] was used instead of the
value originally used by Nordin, Peacock, and Wilkinson
[2].
In this report, we show that the conclusions from afore-
mentioned analysis done in a synthetic medium [9] apply
to whole urine collected from human beings suffering
from stones. Data were derived from our kidney stone
registry [10], comprised of 667 patients with predom-
inantly calcium oxalate stones in whom detailed mea-
surements of urinary constituents were available for the
calculation of urinary saturation of calcium oxalate by
Equil 2 program [8].
METHODS
Patient data
A total of 2209 patients with stones were included in
the stone registry, whereby their data obtained during
baseline ambulatory evaluation were entered onto the
computer database. Patients who satisfied the following
criteria were selected: (1) stone retrieved within 6 months
of evaluation showing on analysis >70% calcium oxalate
in composition; (2) one or two 24-hour urine samples col-
lected during a random diet analyzed for a full set of stone
risk factors [11], including calcium, oxalate, citrate, mag-
nesium, phosphorus, uric acid, sodium, potassium, pH
and total volume; (3) relative saturation ratio (RSR) of
calcium oxalate calculated by the Equil 2 program [8]; (4)
body weight and age; (5) stone formation rate or the num-
ber of stones formed (passed or removed) during 3 years
preceding baseline evaluation, determined from history,
review of patient data, and report of referring physician
for stone passage, procedures for removal of stones and
appearance on x-ray films; (6) number of stone surgeries
or procedures (extracorporeal shock wave lithotripsy, en-
doscopic and ureteroscopic approaches, basket removal,
and open surgery) for the removal of stones performed
during preceding 3 years; and (7) adult patients ≥ 20 years
old of either gender. None of the patients took drugs
for the control of stone formation, calcium supplements,
or pharmacologic doses of vitamin D preparations for
at least 2 weeks prior to baseline evaluation. Patients
with primary hyperparathyroidism, distal renal tubular
acidosis, enteric or primary hyperoxaluria, infection of
the urinary tract with urea-splitting organisms, or cystin-
Table 1. Baseline presentation
Mean ± SD Median (range)
Age years 43.3 ± 11.9 42 (21–78)
Weight kg 79.7 ± 18.8 78.2 (38.2–204.5)
Urinary calcium mg/L 159 ± 86 147 (9–677)
Urinary oxalate mg/L 21.1 ± 10.5 19.3 (2.0–121.1)
Urinary citrate mg/L 329 ± 223 292 (4–2550)
Urinary magnesium mg/L 63.3 ± 30.4 57.9 (5.9–274.0)
Urinary phosphorus mg/L 605 ± 255 568 (136–1890)
Urinary uric acid mg/L 378 ± 154 364 (77–1502)
Urinary sodium mEq/L 110 ± 46 107 (13–245)
Urinary potassium mEq/L 32.2 ± 13.5 30.2 (5.7–83.2)
Urinary pH 6.00 ± 0.37 6.01 (4.98–7.25)
Urinary total volume mL/day 1761 ± 805 1593 (288–6905)
Relative saturation ratio, 8.91 ± 4.41 8.21 (0.57–37.4)
calcium oxalate
Relative saturation ratio, Brushite 2.59 ± 1.86 2.19 (0.06–12.09)
For all parameters, the number of subjects evaluated was 667. To convert
mg to mmol, divide by 40 for calcium, 88 for oxalate, 189 for citrate, 24.32 for
magnesium, 31 for phosphorus, and 168 for uric acid.
uria were excluded. Some patients evaluated in the 1970s
were not included in this report, since they did not have
analysis of urinary uric acid or citrate. Those without ac-
curate stone analysis were not considered here. There
were a total of 667 patients (197 women and 470 men)
who satisfied all of the above criteria; they comprised the
data set for this report.
Urinary stone risk factors were analyzed by previously
described methods [11]. RSR represented the ratio of ac-
tivity product and the thermodynamic solubility product
of calcium oxalate. A value of 1 represented saturation,
>1 supersaturation, and <1 undersaturation [10]. Among
those with two random urine collections, the mean values
were utilized in this analysis.
Statistical methods
Objective of this retrospective data analysis was to seek
factors that determine urinary RSR of calcium oxalate.
Spearman correlation coefficients were determined in or-
der to evaluate the association between RSR of calcium
oxalate and urinary concentrations of calcium, oxalate,
citrate, magnesium, phosphorus, uric acid, sodium, potas-
sium, and urinary pH, total volume, age, and weight. Ad-
justed Spearman correlation coefficients were obtained
after correcting for above urinary analytes. The factor
being tested for association with RSR calcium oxalate
was omitted as a partial variable.
RESULTS
Baseline presentation
Baseline data are presented in Table 1. Urinary cal-
cium concentration varied widely (9 to 677 mg/L) as did
urinary oxalate concentration (2.0 to 121.1 mg/L). Daily
urinary calcium excretion was high at 280 mg/day (normal
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Fig. 1. Theoretic relationship between satu-
ration of calcium oxalate [relative saturation
ratio (RSR CaOx)] and concentration of cal-
cium (Ca) or oxalate (Ox). RSR of calcium
oxalate was calculated from mean values for
urinary constituents derived from 667 patients
with predominantly calcium oxalate stones,
while calcium and oxalate were mathemati-
cally adjusted. The stability constant of cal-
cium oxalate complex was assumed to be 7.07
× 103 (A), whereas it was considered to be
2.746 × 103 (B). For convenience, the same
value was used as the thermodynamic solubil-
ity product in calculating RSR (A) and (B). To
convert mg to mmol, divide by 40 for calcium,
and by 88 for oxalate.
<250 mg/day on a random diet in our laboratory [11]),
and urinary citrate was within normal limits at 579 mg/day
(mean normal 640 mg/day). Mean values for other uri-
nary risk factors were within normal limits.
“Theoretic” relationship between RSR of calcium
oxalate and calcium or oxalate concentration using
different stability constants
By using the mean values for stone risk factors from
667 patients shown in Table 1, RSR of calcium oxalate
was calculated using Equil 2 while using stability con-
stant for calcium oxalate complex of 7.07 × 103 (from
Nordin, Peacock, and Wilkinson [2]) or 2.746 × 103 (from
Finlayson, Roth, and DuBois [7]). For each stability con-
stant, calcium concentration was varied from 0 to mean
+ 2 SD, while oxalate concentration was kept constant at
the group mean. Conversely, oxalate concentration was
varied from 0 to mean + 2 SD, while calcium concentra-
tion was kept constant at the mean value.
When the higher stability constant was used, RSR of
calcium oxalate progressively rose with increasing ox-
alate concentration, whereas it reached a plateau at high
calcium concentrations at a level much lower than that of
corresponding oxalate concentrations (Fig. 1A). In con-
trast, when the lower stability constant [7] was used as
in Equil 2 [8], the rise in RSR with increasing oxalate
concentration was similar to that of increasing calcium
concentration (Fig. 2B). The two curves departed only at
high concentrations, with RSR from oxalate being about
15% higher than RSR from calcium, owing to the appear-
ance of a plateau in the calcium curve. We next examined
how this theoretic relationship compares with the actual
data.
“Actual” relationship between urinary RSR of calcium
oxalate and urinary calcium or oxalate concentration
Individual RSR of calcium oxalate calculated by Equil
2 (with stability constant of 2.746 × 103) from all 667
patients were utilized to examine the determinants of
RSR of calcium oxalate. Without adjustment for vari-
ables, RSR calcium oxalate was highly and significantly
correlated with urinary concentration of calcium as well
as that of oxalate (r = 0.75 for calcium and 0.73 for ox-
alate, P <0.0001). RSR calcium oxalate was significantly
and positively correlated with urinary concentration of
citrate, magnesium, phosphorus, uric acid, sodium, and
potassium, though less robust (r < 0.6) than with urinary
concentrations of calcium and oxalate. It was significantly
and inversely correlated with urinary pH and total vol-
ume (r < −0.5).
After adjustment for variables, the significant correla-
tions between RSR calcium oxalate versus calcium and
oxalate concentrations remained (r = 0.57 for calcium
and 0.60 for oxalate, P < 0.0001). Though not robust (r =
−0.2 to −0.4), there was a significant negative correlation
between RSR calcium oxalate versus citrate, magnesium,
phosphorus, and sodium.
In Figure 2A, mean RSR of calcium oxalate was calcu-
lated for each 25 mg/L interval of urinary calcium concen-
tration over the range of 0% to 96% of values from 667
patients. Actual values closely resembled the theoretical
curve obtained by using the lower stability constant (from
Fig. 1B). In Figure 2B, mean RSR of calcium oxalate was
calculated for each 5 mg/L interval of urinary oxalate con-
centration over the range of 0% to 96% of values from
667 patients. The actually derived values approximated
the theoretical curve (Fig. 1B).
When drawn to the same scale of 0% to 96% range
of urinary calcium and oxalate concentrations from 667
patients, a plot of RSR of calcium oxalate against urinary
calcium concentration (in 25 mg/L intervals) was virtually
indistinguishable from the plot of RSR against urinary
oxalate concentration (in 5 mg/L intervals) (Fig. 3).
DISCUSSION
This retrospective data analysis was undertaken in or-
der to critically appraise the long-held view that urinary
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Fig. 2. Actual relationship between saturation of calcium oxalate and
calcium or oxalate concentration. Relative saturation ratio (RSR) of
calcium oxalate was individually, and the mean value derived for each
25 mg/L interval (or 0.625 mmol/L) of urinary calcium concentration
and each 5 mg/L (0.057 mmol/L) interval of urinary oxalate concentra-
tion over a range of 0% to 96% from 667 patients. Each dot represents
group mean at each interval. The curves from Figure 1B are drawn to
show approximation of actual with theoretic data. (A) The relationship
between RSR of calcium oxalate and calcium concentration. (B) The
relationship of RSR with oxalate concentration.
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Fig. 3. Approximation of the actual relationship between relative sat-
uration ratio (RSR) of calcium oxalate and calcium concentration by
the actual relationship between RSR and oxalate concentration. Group
mean RSRs of calcium oxalate for each 25 mg/L intervals of calcium
concentration from 667 patients are shown (•), and group mean RSRs
for each 5 mg/L intervals of oxalate are depicted (◦).
oxalate is more important than urinary calcium owing to
the formation of soluble calcium oxalate complex [2–5].
In urine samples obtained from 667 patients with predom-
inantly calcium oxalate stones (>70% on stone compo-
sition) on a random diet, urinary saturation of calcium
oxalate was calculated using Equil 2 program [8]. We
found that urinary calcium concentration was equally ef-
fective as urinary oxalate concentration in increasing uri-
nary saturation of calcium oxalate.
The persisting belief that urinary saturation of calcium
oxalate is much more dependent on urinary oxalate than
on calcium was derived by using stability constant of
7.07 × 103 that probably exaggerated the formation of
calcium oxalate complex [2]. The same authors of that
report [2] later conceded that the constant used earlier
was too high [6], and suggested a value of 1.9 × 103.
The correctness of the latter value was espoused from
the close agreement between calculated and measured
values of ionized calcium concentration [6]. In this study,
we employed the widely accepted stability constant of
2.746 × 103, a value utilized in Equil 2, a computer pro-
gram considered to be the gold standard for estimating
urinary saturation of stone forming salts [8]. This con-
stant was derived experimentally by Finlayson, Roth, and
DuBois [7] from solubility studies conducted at body tem-
perature. A similar value was obtained experimentally by
another renowned group in physical solution chemistry
[12].
From theoretic grounds, the formation of calcium ox-
alate complex should lower the ionized concentration of
calcium and oxalate, and thereby reduce the saturation of
calcium oxalate. Since urinary calcium is proportionately
much higher than urinary oxalate, the fractional decline
in ionized oxalate should be greater than that of ionized
calcium. Thus, a rise in urinary calcium concentration is
expected to produce a less prominent increase in urinary
saturation of calcium oxalate than a rise in urinary oxalate
concentration. The use of a high stability constant would
exaggerate complex formation, cause a proportionately
greater fractional decline in ionized oxalate, and further
blunt the effect of calcium on urinary saturation of cal-
cium oxalate. Thus, our failure to show a more prominent
effect of oxalate over calcium on saturation of calcium ox-
alate might have resulted from the use of lower stability
constant.
In this study, we tested the above hypothesis incorpo-
rating the following unique features. First, we utilized
stone risk factors from 24-hour random urine samples,
collected from 667 patients with predominantly calcium
oxalate stones (>70% on stone analysis). Thus, the data
were derived in actual urine samples rather than synthetic
medium [9]. The use of mean values for urinary analytes
from a large number of patients with idiopathic calcium
oxalate nephrolithiasis made the analysis clinically more
relevant.
Second, we constructed theoretic curves depicting de-
pendence of saturation of calcium oxalate on calcium
or oxalate concentration, by taking the mean values for
urinary constituents derived from 667 patients, while
arbitrarily varying calcium or oxalate concentration. With
Equil 2 program, we calculated the saturation of calcium
oxalate using stability constant of calcium oxalate com-
plex of 7.07 × 103 as in the original report by Nordin,
Peacock, and Wilkinson [2], and a value of 2.746 × 103
introduced by Finlayson, Roth, and DuBois [7] and con-
tained in Equil 2. When the higher stability constant was
used, we found qualitatively the same result as reported
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by Nordin, Peacock, and Wilkinson [2]. A rise in calcium
concentration produced a much less prominent increase
in the saturation of calcium oxalate, compared with a rise
in urinary oxalate. However, when a more accurate stabil-
ity constant of Finlayson, Roth, and DuBois [7] was em-
ployed, urinary calcium was equally effective as urinary
oxalate in increasing the urinary saturation of calcium ox-
alate, confirming a similar analysis performed earlier in a
synthetic medium [9].
Third, we compared the theoretic curves described
above, with the actual curves obtained from individual
values obtained from 667 patients with predominantly
calcium oxalate stones. In constructing the actual curves,
mean RSR of calcium oxalate was calculated for each
25 mg/L interval of calcium and for each 5 mg/L interval
of oxalate. Each interval therefore represented a compos-
ite of varying urinary composition from different patients
with stones. In contrast, the theoretic curves were con-
structed while other urinary analytes were kept the same
as the mean values for the whole group of patients with
stones. Thus, the outcome from the actual curves could
not have been predicted from the theoretic curves just
because the same stability constant had been used. The
theoretic and actual curves closely approximated each
other. Moreover, the actual curves for calcium and ox-
alate, derived at varying intervals of calcium and oxalate
from urine samples of a large group of well-characterized
patients with calcium oxalate stones, were nearly
identical.
Fourth and finally, in comparing calcium and oxalate
curves, the upper limits for calcium and oxalate concen-
trations were not arbitrarily set, but represented exper-
imentally derived 96 percentile value from our patients
with stones. Thus, we were able to examine the effect of
calcium and oxalate at urinary concentration ranges oc-
curring in most patients with idiopathic calcium oxalate
nephrolithiasis. In some reports [13], the upper limit of
calcium was set at an unusually high value at which a
flattening of calcium curves becomes more prominent.
We therefore believe that the prior reports [3] showing
a greater dependence of the saturation of calcium oxalate
on oxalate than on calcium concentration may have ex-
aggerated the degree of calcium oxalate complexation.
Using the state-of-the-art Equil 2 computer program [8]
that utilized a lower value for the stability constant of cal-
cium oxalate [7], the degree of increase in the saturation
of calcium oxalate with rising calcium concentration was
found to be equivalent to that obtained by a rise in ox-
alate, and more marked than in the earlier study [2] (that
had used a higher value for the stability constant).
Our findings are not at variance with an early review
by Finlayson [14] in which a much more prominent role
of oxalate was claimed. Finlayson’s view was based on a
study by Marshall et al [15], who had examined diurnal
variation in urinary composition and saturation of cal-
cium oxalate calculated by using the higher stability con-
stant for calcium oxalate. In recalculating the same data
with the use of Equil 2 program, we found that the sub-
stitution of urinary oxalate from stone-formers into the
urinary composition of normal subjects increased RSR of
calcium oxalate by 28% (unpublished data of authors).
Substitution of calcium resulted in a similar increase of
26%.
We are not casting doubt on the importance of uri-
nary oxalate in stone formation. Rather, we are suggest-
ing that urinary calcium exerts a similar effect as oxalate
within the 4% to 96% range of calcium and oxalate con-
centrations encountered among patients with idiopathic
calcium oxalate nephrolithiasis.
Nor are we disparaging the importance of oxalate in
the formation of the stone nidus, suggested by many stud-
ies in animal models and cell systems. However, some of
these studies employed high oxalate loads or exposure,
creating a situation analogous to enteric hyperoxaluria
in human beings, rather than idiopathic calcium oxalate
nephrolithiasis, the target of our study. Relevant here is
the recent work by Evan et al [16], who had obtained pap-
illary biopsies in human beings intraoperatively. Among
patients with idiopathic calcium oxalate nephrolithiasis,
the nidus began as hydroxyapatite deposition in the base-
ment membrane of the thin loop of Henle. The plaque
formation was correlated with hypercalciuria, not with
urinary oxalate. Among patients with enteric hyperox-
aluria, the nidus began as hydroxyapatite crystals de-
posited within the lumen of distal collecting ducts.
CONCLUSION
Urinary calcium exerts a similar effect as urinary ox-
alate in increasing urinary saturation of calcium ox-
alate among patients with predominantly calcium oxalate
stones. This assessment is based on a reasonably safe as-
sumption that the stability constant for calcium oxalate
complex utilized in the Equil 2 program is accurate.
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